Kesner L, Yu W S, Bradlow H L, Breed C W, Fleisher M
Department of Biochemistry, SUNY-Health Science Center, Brooklyn 11203.
Cancer Res. 1988 Nov 15;48(22):6379-83.
Cyst fluid from women with gross cystic breast disease was found to contain protease activity when assayed against [14C]albumin. At least six different proteases were detected when the fluid was fractionated by a combination of S-300 Sephacel, hydroxylapatite, and DEAE-Sephacel chromatographic techniques. The distribution of the proteases appeared to be related to the ionic composition of the fluids. A major protease component, found in both high Na and high K fluids, was isolated. It showed chymotryptic cleavage characteristics against the beta-chain of insulin. It was partially inhibited by alpha 2-macroglobulin, N-tosyl-L-phenylalanine chloromethyl ketone, and benzamidine but not by leupeptin, pepstatin, N-tosyl-L-lysine chloromethyl ketone, or alpha 1-protease inhibitor. The protease has an apparent molecular weight of 110,000 with Mr 24,000 subunits. This protease may be identical or closely associated with Haagensen's GCDFP-24 progesterone binding protein which was isolated in a similar manner. An imbalance between protease and protease inhibitors in cyst fluid may account for gross cyst formation and may be involved in the tumorigenic process. The accumulation of poorly diffusible peptide fragments, as a result of protease activity, would increase the oncotic pressure leading to enlargement of the cyst cavity as water enters to reestablish osmotic equilibrium.
对患乳腺大囊性病女性的囊液进行检测时,发现其在以[14C]白蛋白为底物进行分析时有蛋白酶活性。当采用S-300 Sephacel、羟基磷灰石和DEAE-Sephacel色谱技术组合对囊液进行分级分离时,至少检测到六种不同的蛋白酶。蛋白酶的分布似乎与囊液的离子组成有关。在高钠和高钾囊液中均发现了一种主要的蛋白酶成分,并将其分离出来。它对胰岛素β链表现出胰凝乳蛋白酶裂解特性。它部分受α2-巨球蛋白、N-甲苯磺酰-L-苯丙氨酸氯甲基酮和苯甲脒抑制,但不受亮抑酶肽、胃蛋白酶抑制剂、N-甲苯磺酰-L-赖氨酸氯甲基酮或α1-蛋白酶抑制剂抑制。该蛋白酶的表观分子量为110,000,由分子量为24,000的亚基组成。这种蛋白酶可能与以类似方式分离得到的哈根森GCDFP-24孕酮结合蛋白相同或密切相关。囊液中蛋白酶与蛋白酶抑制剂之间的失衡可能是乳腺大囊肿形成的原因,并且可能参与肿瘤发生过程。由于蛋白酶活性导致的难扩散肽片段的积累,会随着水进入以重建渗透平衡而增加渗透压,导致囊肿腔扩大。